Assamicain A



Compound IDCDAMM01096
Common nameAssamicain A
IUPAC name[5,7-dihydroxy-8-[2-(3,4,5-trihydroxybenzoyl)oxy-3-(2,4,6-trihydroxyphenyl)-1-(3,4,5-trihydroxyphenyl)propyl]-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate
Molecular formulaC44H36O22

Experimental data

Retention time0.5
Adduct[M+H]+
Actual mz917.179
Theoretical mz917.177
Error1.88
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9161

Identifiers and class information

Inchi keySKYSKYXPHIEIOH-UHFFFAOYNA-N
SmilesO=C(OC1CC2=C(O)C=C(O)C(=C2OC1C3=CC(O)=C(O)C(O)=C3)C(C4=CC(O)=C(O)C(O)=C4)C(OC(=O)C5=CC(O)=C(O)C(O)=C5)CC=6C(O)=CC(O)=CC6O)C7=CC(O)=C(O)C(O)=C7
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)14
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)26
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)916.755
Computed dipole moment(dipole)2.195
Total solvent accessible surface area (SASA)1153.57
Hydrophobic component of SASA (FOSA)32.949
Hydrophilic component of SASA (FISA)729.98
Pie component of the SASA (PISA)390.639
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2299.51
Number of hydrogen bond donors (donorHB)17
Number of hydrogen bond acceptors (accptHB)17.5
Free energy of solvation of dipole (dip^2/V)0.0020959
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0625488
Globularity descriptor (glob)0.730374
Predicted polarizability in cubic angstroms (QPpolrz)72.908
Predicted hexadecane/gas partition coefficient (QPlogPC16)31.716
Predicted octanol/gas partition coefficient (QPlogPoct)61.33
Predicted water/gas partition coefficient (QPlogPw)46.518
Predicted octanol/water partition coefficient (QPlogPo/w)-1.144
Predicted aqueous solubility (QPlogS)-4.107
Conformation-independent predicted aqueous solubility (CIQPlogS)-11.055
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.758
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.001
Predicted brain/blood partition coefficient (QPlogBB)-10.127
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0
Predicted skin permeability, log Kp (QPlogKp)-11.101
PM3 calculated ionization potential (IP(ev))8.816
PM3 calculated electron affinity (EA(eV))0.673
Number of likely metabolic reactions (#metab)21
Prediction of binding to human serum albumin (QPlogKhsa)-0.921
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)422.662
Number of nitrogen and oxygen atoms (#NandO)22
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P05067APPBeta amyloid A4 proteinT87024SwissTargetPrediction
Q14534SQLESqualene monooxygenase (by homology)T93344SwissTargetPrediction
P05121SERPINE1Plasminogen activator inhibitor-1T15556SEA
P08183ABCB1P-glycoprotein 1T25258SEA
Q13627DYRK1ADual-specificity tyrosine-phosphorylation regulated kinase 1AT92803SwissTargetPrediction
P50281MMP14Matrix metalloproteinase 14T65019SwissTargetPrediction
P52209PGD6-phosphogluconate dehydrogenaseT76497SwissTargetPrediction and SEA
P22083FUT4Fucosyltransferase 4T51146SwissTargetPrediction
P42224STAT1Signal transducer and activator of transcription 1-alpha/betaT64205SwissTargetPrediction
P10636MAPTMicrotubule-associated protein tauT45593SwissTargetPrediction
Q99417MYCBPMYCBP messenger RNAT37298SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T93344DI0118Dermatophytosis[ICD-11: 1F28]Q14534SQLE
T93344DI0385Skin fungal infection disorder[ICD-11: EA60]Q14534SQLE
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T92803DI0113Cytomegaloviral disease[ICD-11: 1D82]Q13627DYRK1A
T65019DI0178Hepatic fibrosis/cirrhosis[ICD-11: DB93]P50281MMP14
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T51146DI0441Appendicitis[ICD-11: DB10]P22083FUT4
T64205DI0383Skin and skin-structure infection[ICD-11: 1F28-1G0Z]P42224STAT1
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025